Neumora Therapeutics, Inc.
NMRA
$2.27
$0.041.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.74% | -41.45% | -41.01% | -32.25% | -33.02% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -8.72% | 39.07% | -5.72% | -70.75% | 292.27% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -91.69% | -80.75% | -91.30% |
| Total Current Assets | -49.20% | -44.04% | -42.44% | -34.34% | -33.69% |
|
|
|||||
| Total Current Assets | -49.20% | -44.04% | -42.44% | -34.34% | -33.69% |
| Net Property, Plant & Equipment | -85.90% | -87.49% | -68.16% | -57.47% | -50.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -75.43% | -- | -- | -- |
| Total Assets | -49.56% | -44.66% | -42.97% | -36.12% | -35.28% |
|
|
|||||
| Total Accounts Payable | -91.01% | -40.48% | -29.49% | 881.31% | 173.98% |
| Total Accrued Expenses | 9.77% | 10.65% | 34.78% | 15.69% | -2.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.67% | -95.26% | -73.13% | -45.15% | -19.22% |
| Total Finance Division Other Current Liabilities | -58.65% | -33.83% | -8.27% | -4.32% | -10.74% |
| Total Other Current Liabilities | -58.65% | -33.83% | -8.27% | -4.32% | -10.74% |
| Total Current Liabilities | -18.59% | -8.51% | 15.34% | 19.02% | 9.00% |
|
|
|||||
| Total Current Liabilities | -18.59% | -8.51% | 15.34% | 19.02% | 9.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -85.81% | -70.74% |
| Total Liabilities | 43.63% | 76.38% | 10.58% | 10.28% | -0.80% |
|
|
|||||
| Common Stock & APIC | 3.95% | 4.47% | 5.22% | 5.26% | 9.15% |
| Retained Earnings | -26.60% | -30.90% | -34.08% | -34.66% | -49.39% |
| Treasury Stock & Other | -91.43% | 91.98% | 97.97% | 181.58% | 133.76% |
| Total Common Equity | -58.79% | -52.03% | -46.21% | -38.80% | -37.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -58.79% | -52.03% | -46.21% | -38.80% | -37.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -58.79% | -52.03% | -46.21% | -38.80% | -37.44% |
|
|
|||||